The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 ...

Mesoscale eddies, oceanic gyres about 100 kilometers in diameter, are ubiquitous features of the global ocean and play a ...

The following is a summary of “Effect of manual decongestive therapy on cardiac preload in critically ill patients: a ...

Dr. Georgeanne Botek, DPM, is a podiatrist who has been part of the Cleveland Clinic’s Department of Orthopaedic Surgery ...

European shares were higher today. The eurozone's STOXX 600 gained 0.15%, Germany's DAX 40 rose 0.28% and France's CAC 40 ...

Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial’s primary ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient populationUBX1325 was ...

Asthma and type 2 diabetes are two important causes of morbidity globally. We examined both the association of type 2 diabetes with asthma in Swedish adults and the familial co-aggregation of the ...

Reflections on a recent NEJM publication highlight the importance of identifying and addressing the pathologic process of ...

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

The first in-human trials for an artificial lamellar implant demonstrates the device’s potential to treat corneal edema.